Students for Life America, a prominent anti-abortion organization, announced on Thursday its intent to initiate legal action against the Food and Drug Administration (FDA). The core of the group's argument rests on the environmental impact of mifepristone, a drug used for medication abortions. The organization contends that the FDA has failed to properly regulate the disposal of medical waste generated by the drug's use.

According to the group, the environmental consequences of this waste are significant, alleging that over 50 tons of medical waste are produced as a result of the drug's distribution. The legal strategy hinges on the Endangered Species Act, with the group asserting that the FDA's current oversight policies do not adequately protect wildlife or ecosystems from potential contamination. This move represents a strategic shift in the anti-abortion movement, which has increasingly sought to utilize environmental and administrative law to challenge the accessibility of abortion-related services.

The FDA has not yet provided a formal response to the notice of intent to sue. The legal filing serves as a formal precursor to a lawsuit, providing the agency with a window to address the group's grievances before litigation proceeds in federal court. This effort is part of a broader, yearslong campaign by the organization to restrict access to mifepristone by targeting the regulatory framework that governs its approval and distribution.